Michał Szczypior, MD, PhD is a graduate of the Medical University of Gdańsk. He has been working at the Department of Urology of the University Clinical Centre in Gdańsk since 2014. In 2018 he completed an internship at the Department of Urology of the Catholic University of Leuven in Belgium. In 2019 he defended his doctoral dissertation under the title “Evaluation of treatment efficiency and improvement of quality of life in patients diagnosed with refractory idiopathic overactive bladder treated with botulinum toxin and methylene blue”. He is a member of the Polish Urological Association and the European Association of Urology.